Home › Companies › FENNEC PHARMACEUTICALS INC. › 2023-2024
At FENNEC PHARMACEUTICALS INC.'s shareholder meeting held June 25, 2024, in the 2023-2024 proxy season, 81 asset managers reported how they voted on 7 ballot items in their SEC Form N-PX filings, covering 624 separate fund positions. On the most widely held item on that ballot — EXECUTIVE COMPENSATION To vote, on an advisory (non-binding) basis, on the compensation of the… — FENNEC PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: FENNEC PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 25, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and FENNEC PHARMACEUTICALS INC.’s Form 8-K, filed June 25, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 25, 2024: 7 items on FENNEC PHARMACEUTICALS INC.’s Form 8-K, filed June 25, 2024: 2 approved · 5 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore FENNEC PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are FENNEC PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 25, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dr. Khalid Islam | 10,100,238 | -- | -- | 371,270 | 6,091,979 | 96% | Not verified | — |
| Elect Director: Chris A. Rallis | 9,688,517 | -- | -- | 782,991 | 6,091,979 | 93% | Not verified | — |
| Elect Director: Marco Brughera | 9,801,305 | -- | -- | 670,203 | 6,091,979 | 94% | Not verified | — |
| Elect Director: Jodi Cook | 8,991,182 | -- | -- | 1,480,326 | 6,091,979 | 86% | Not verified | — |
| Elect Director: Rostislav Raykov | 9,859,679 | -- | -- | 611,829 | 6,091,979 | 94% | Not verified | — |
| 2. Resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board of Directors to fix their remuneration | 16,225,975 | 0 | -- | 337,512 | 0 | 98% | Approved | — |
| 3. Resolution to vote on the advisory vote on executive compensation | 9,830,484 | 346,881 | 294,143 | -- | 6,091,979 | 97% | Approved | — |
Source: FENNEC PHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 25, 2024 — read the filing on EDGAR.
Each item below shows how the 81 asset managers that disclosed a FENNEC PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Dr. Jodi Cook
FENNEC PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jodi Cook”): 8,991,182 for, 1,480,326 withheld, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 1,454,836 for, 107,813 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 717,680 | 0 | 0 | 0 | For |
| BlackRock | 445,830 | 0 | 0 | 0 | For |
| Fidelity | 172,462 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 41,497 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 34,891 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 32,046 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 14,900 | Withhold |
| Equitable | 10,567 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 10,398 | Withhold |
| Northern Trust | 8,063 | 0 | 0 | 0 | For |
| John Hancock | 7,874 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
| Pacific Life | 6,442 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 6,362 | Withhold |
| Brighthouse | 6,156 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,035 | 0 | 0 | 0 | For |
| 1290 Funds | 5,782 | 0 | 0 | 0 | For |
| Nationwide | 3,780 | 0 | 0 | 0 | For |
| ProShares | 3,393 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 3,205 | 0 | 0 | 0 | For |
| GPS Funds I | 3,124 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 3,100 | 0 | 0 | 0 | For |
| DWS | 2,792 | 0 | 0 | 0 | For |
| Voya | 2,299 | 0 | 0 | 0 | For |
| Principal | 2,091 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Dr. Khalid Islam
FENNEC PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dr. Khalid Islam”): 10,100,238 for, 371,270 withheld, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 1,561,150 for, 1,499 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 717,680 | 0 | 0 | 0 | For |
| BlackRock | 445,830 | 0 | 0 | 0 | For |
| Fidelity | 172,462 | 0 | 0 | 0 | For |
| Charles Schwab | 41,497 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 34,891 | 0 | 0 | 0 | For |
| TIAA | 32,046 | 0 | 0 | 0 | For |
| Lincoln Financial | 14,900 | 0 | 0 | 0 | For |
| Equitable | 10,567 | 0 | 0 | 0 | For |
| Global X | 10,398 | 0 | 0 | 0 | For |
| Northern Trust | 8,063 | 0 | 0 | 0 | For |
| John Hancock | 7,874 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
| Pacific Life | 6,442 | 0 | 0 | 0 | For |
| State Street | 6,362 | 0 | 0 | 0 | For |
| Brighthouse | 6,156 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,035 | 0 | 0 | 0 | For |
| 1290 Funds | 5,782 | 0 | 0 | 0 | For |
| Nationwide | 3,780 | 0 | 0 | 0 | For |
| ProShares | 3,393 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 3,205 | 0 | 0 | 0 | For |
| GPS Funds I | 3,124 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 3,100 | 0 | 0 | 0 | For |
| DWS | 2,792 | 0 | 0 | 0 | For |
| Voya | 2,299 | 0 | 0 | 0 | For |
| Principal | 2,091 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Dr. Marco Brughera
FENNEC PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Marco Brughera”): 9,801,305 for, 670,203 withheld, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 1,529,104 for, 33,545 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 717,680 | 0 | 0 | 0 | For |
| BlackRock | 445,830 | 0 | 0 | 0 | For |
| Fidelity | 172,462 | 0 | 0 | 0 | For |
| Charles Schwab | 41,497 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 34,891 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 32,046 | Withhold |
| Lincoln Financial | 14,900 | 0 | 0 | 0 | For |
| Equitable | 10,567 | 0 | 0 | 0 | For |
| Global X | 10,398 | 0 | 0 | 0 | For |
| Northern Trust | 8,063 | 0 | 0 | 0 | For |
| John Hancock | 7,874 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
| Pacific Life | 6,442 | 0 | 0 | 0 | For |
| State Street | 6,362 | 0 | 0 | 0 | For |
| Brighthouse | 6,156 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,035 | 0 | 0 | 0 | For |
| 1290 Funds | 5,782 | 0 | 0 | 0 | For |
| Nationwide | 3,780 | 0 | 0 | 0 | For |
| ProShares | 3,393 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 3,205 | 0 | 0 | 0 | For |
| GPS Funds I | 3,124 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 3,100 | 0 | 0 | 0 | For |
| DWS | 2,792 | 0 | 0 | 0 | For |
| Voya | 2,299 | 0 | 0 | 0 | For |
| Principal | 2,091 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Mr. Chris A. Rallis
FENNEC PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Chris A. Rallis”): 9,688,517 for, 782,991 withheld, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 1,516,501 for, 46,148 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 717,680 | 0 | 0 | 0 | For |
| BlackRock | 445,830 | 0 | 0 | 0 | For |
| Fidelity | 172,462 | 0 | 0 | 0 | For |
| Charles Schwab | 41,497 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 34,891 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 32,046 | Withhold |
| Lincoln Financial | 14,900 | 0 | 0 | 0 | For |
| Equitable | 6,027 | 0 | 0 | 4,540 | Mixed |
| Global X | 10,398 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 8,063 | Withhold |
| John Hancock | 7,874 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
| Pacific Life | 6,442 | 0 | 0 | 0 | For |
| State Street | 6,362 | 0 | 0 | 0 | For |
| Brighthouse | 6,156 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,035 | 0 | 0 | 0 | For |
| 1290 Funds | 5,782 | 0 | 0 | 0 | For |
| Nationwide | 3,780 | 0 | 0 | 0 | For |
| ProShares | 3,393 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 3,205 | 0 | 0 | 0 | For |
| GPS Funds I | 3,124 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 3,100 | 0 | 0 | 0 | For |
| DWS | 2,792 | 0 | 0 | 0 | For |
| Voya | 2,299 | 0 | 0 | 0 | For |
| Principal | 2,091 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Mr. Rostislav Raykov
FENNEC PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Rostislav Raykov”): 9,859,679 for, 611,829 withheld, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 1,562,649 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 717,680 | 0 | 0 | 0 | For |
| BlackRock | 445,830 | 0 | 0 | 0 | For |
| Fidelity | 172,462 | 0 | 0 | 0 | For |
| Charles Schwab | 41,497 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 34,891 | 0 | 0 | 0 | For |
| TIAA | 32,046 | 0 | 0 | 0 | For |
| Lincoln Financial | 14,900 | 0 | 0 | 0 | For |
| Equitable | 10,567 | 0 | 0 | 0 | For |
| Global X | 10,398 | 0 | 0 | 0 | For |
| Northern Trust | 8,063 | 0 | 0 | 0 | For |
| John Hancock | 7,874 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
| Pacific Life | 6,442 | 0 | 0 | 0 | For |
| State Street | 6,362 | 0 | 0 | 0 | For |
| Brighthouse | 6,156 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,035 | 0 | 0 | 0 | For |
| 1290 Funds | 5,782 | 0 | 0 | 0 | For |
| Nationwide | 3,780 | 0 | 0 | 0 | For |
| ProShares | 3,393 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 3,205 | 0 | 0 | 0 | For |
| GPS Funds I | 3,124 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 3,100 | 0 | 0 | 0 | For |
| DWS | 2,792 | 0 | 0 | 0 | For |
| Voya | 2,299 | 0 | 0 | 0 | For |
| Principal | 2,091 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: EXECUTIVE COMPENSATION To vote, on an advisory (non-binding) basis, on the compensation of the Corporation's named executive officers.
FENNEC PHARMACEUTICALS INC.’s own tally for this item (“3. Resolution to vote on the advisory vote on executive compensation”): 9,830,484 for, 346,881 against — passed, per its Form 8-K filed June 25, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The resolution to vote on the advisory vote on executive compensation was approved based on the following vote:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of FENNEC PHARMACEUTICALS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (2 managers, 22,839 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 717,680 | 0 | 0 | 0 | For |
| BlackRock | 445,830 | 0 | 0 | 0 | For |
| Fidelity | 172,462 | 0 | 0 | 0 | For |
| Charles Schwab | 41,497 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 34,891 | 0 | 0 | 0 | For |
| TIAA | 32,046 | 0 | 0 | 0 | For |
| Lincoln Financial | 14,900 | 0 | 0 | 0 | For |
| Equitable | 10,567 | 0 | 0 | 0 | For |
| Global X | 10,398 | 0 | 0 | 0 | For |
| Northern Trust | 8,063 | 0 | 0 | 0 | For |
| John Hancock | 7,874 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
| Pacific Life | 6,442 | 0 | 0 | 0 | For |
| State Street | 6,362 | 0 | 0 | 0 | For |
| Brighthouse | 6,156 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,035 | 0 | 0 | 0 | For |
| 1290 Funds | 5,782 | 0 | 0 | 0 | For |
| Nationwide | 3,780 | 0 | 0 | 0 | For |
| ProShares | 3,393 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 3,205 | 0 | 0 | 0 | For |
| GPS Funds I | 3,124 | 0 | 0 | 0 | For |
| DWS | 2,792 | 0 | 0 | 0 | For |
| Voya | 2,299 | 0 | 0 | 0 | For |
| Principal | 2,091 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,750 | 0 | 0 | 0 | For |
Fund voting reports, all 31 managers: 1,558,050 for, 1,499 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Southpoint Capital Advisors LP | 4,077,214 | 0 | 0 | 0 | For |
| DG Capital Management, LLC | 1,524,726 | 0 | 0 | 0 | For |
| HARBERT FUND ADVISORS, INC. | 466,869 | 0 | 0 | 0 | For |
| State Street | 284,609 | 0 | 0 | 0 | For |
| BlackRock | 250,213 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 183,339 | 0 | 0 | 0 | For |
| Northern Trust | 95,111 | 5 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 76,477 | 0 | 0 | 0 | For |
| CIBC WORLD MARKET INC. | 68,420 | 0 | 0 | 0 | For |
| Charles Schwab | 41,497 | 0 | 0 | 0 | For |
| Bronte Capital Management Pty Ltd. | 32,379 | 0 | 0 | 0 | For |
| Nuveen | 32,046 | 0 | 0 | 0 | For |
| Citadel | 26,033 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 16,960 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 9,762 | 0 | 0 | 0 | For |
| Rhumbline | 8,074 | 358 | 0 | 0 | For |
| John Hancock | 7,924 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 7,675 | 0 | 0 | 0 | For |
| Point72 | 7,626 | 0 | 0 | 0 | For |
| JPMorgan | 7,115 | 0 | 0 | 0 | For |
| Invesco | 0 | 6,972 | 0 | 0 | Against |
| PRINCIPAL GLOBAL INVESTORS | 5,296 | 0 | 0 | 0 | For |
| Goldman Sachs | 4,548 | 0 | 0 | 0 | For |
| AllianceBernstein | 4,540 | 0 | 0 | 0 | For |
| MetLife Investment Management, LLC | 4,526 | 0 | 0 | 0 | For |
Institutional-manager reports, all 58 managers: 7,275,545 for, 13,619 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: APPOINTMENT OF AUDITORS Appointment of Haskell & White LLP as the auditors of the Corporation for the year ending December 31, 2024 and authorizing the directors of the Corporation to fix their remuneration.
FENNEC PHARMACEUTICALS INC.’s own tally for this item (“2. Resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board of Directors to fix their remuneration”): 16,225,975 for, 337,512 withheld — passed, per its Form 8-K filed June 25, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board of Directors to fix their remuneration was approved based on the following vote:”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 1,562,649 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 717,680 | 0 | 0 | 0 | For |
| BlackRock | 445,830 | 0 | 0 | 0 | For |
| Fidelity | 172,462 | 0 | 0 | 0 | For |
| Charles Schwab | 41,497 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 34,891 | 0 | 0 | 0 | For |
| TIAA | 32,046 | 0 | 0 | 0 | For |
| Lincoln Financial | 14,900 | 0 | 0 | 0 | For |
| Equitable | 10,567 | 0 | 0 | 0 | For |
| Global X | 10,398 | 0 | 0 | 0 | For |
| Northern Trust | 8,063 | 0 | 0 | 0 | For |
| John Hancock | 7,874 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
| Pacific Life | 6,442 | 0 | 0 | 0 | For |
| State Street | 6,362 | 0 | 0 | 0 | For |
| Brighthouse | 6,156 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,035 | 0 | 0 | 0 | For |
| 1290 Funds | 5,782 | 0 | 0 | 0 | For |
| Nationwide | 3,780 | 0 | 0 | 0 | For |
| ProShares | 3,393 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 3,205 | 0 | 0 | 0 | For |
| GPS Funds I | 3,124 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 3,100 | 0 | 0 | 0 | For |
| DWS | 2,792 | 0 | 0 | 0 | For |
| Voya | 2,299 | 0 | 0 | 0 | For |
| Principal | 2,091 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 27,322,141 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 2.63% |
| 2 | BlackRock | 1.63% |
| 3 | Fidelity | 0.63% |
| 4 | Charles Schwab | 0.15% |
| 5 | QUANTITATIVE MASTER SERIES LLC | 0.13% |
| 6 | TIAA | 0.12% |
| 7 | Lincoln Financial | 0.05% |
| 8 | Equitable | 0.04% |
| 9 | Global X | 0.04% |
| 10 | Northern Trust | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Southpoint Capital Advisors LP | 14.92% |
| 2 | DG Capital Management, LLC | 5.58% |
| 3 | HARBERT FUND ADVISORS, INC. | 1.71% |
| 4 | State Street | 1.04% |
| 5 | BlackRock | 0.92% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 0.67% |
| 7 | Northern Trust | 0.35% |
| 8 | MELLON INVESTMENTS Corp | 0.28% |
| 9 | CIBC WORLD MARKET INC. | 0.25% |
| 10 | Charles Schwab | 0.15% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Solas Capital Management, LLC | 8.24% | 13G |
| S | 5.57% | 13G |
| BlackRock | 4.44% | 13F |
| DG Capital Management, LLC | 4.08% | 13G |
| Vanguard Group | 3.50% | 13F |
| State Street | 1.11% | 13F |
| Morgan Stanley | 0.85% | 13F |
| Geode Capital | 0.80% | 13F |
| Renaissance Technologies | 0.51% | 13F |
| Northern Trust | 0.42% | 13F |
Percentages above are of 27,322,141 shares outstanding, as reported by FENNEC PHARMACEUTICALS INC. on its Form 10-Q dated May 10, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from FENNEC PHARMACEUTICALS INC.’s 10-Q dated May 10, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
FENNEC PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “FENNEC PHARMACEUTICALS (FENC) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/fennec-pharmaceuticals-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.